Connect with us

Health

Trump says he wants RFK Jr. to investigate potential link between childhood vaccines, autism

Published

8 minute read

From LifeSiteNews

By Doug Mainwaring

‘Well, if you take a look at autism, go back 20 years: Autism was almost nonexistent, it was one out of 100,000. And now it’s close to one out of 100. I mean, what’s happening?’ the president-elect asked.

President-elect Donald Trump told NBC’s Meet the Press that his pick to head the Department of Health and Human Services (HHS), Robert F. Kennedy Jr., will look into potential links between childhood vaccines and autism.

During the Sunday Morning interview with Kristen Welker — which one conservative commentator characterized as “an absolute masterclass” in dealing with hostile corporate journalists — Trump defended RFK Jr.’s quest to investigate the vaccines/autism link as Welker repeatedly insisted that no link exists.

Welker desperately wanted to coax Trump into saying that he’s outright opposed to childhood vaccines, but Trump repeatedly sidestepped her statements, serving up sound judgment for her listeners instead.

Trump would only say that if certain vaccines are shown to be “dangerous for children” they should be eliminated.

“When you look at some of the problems, when you look at what’s going on with disease and sickness in our country, something’s wrong,” Trump emphasized.

“Are you talking about autism?” Welker asked.

“Well, if you take a look at autism, go back 20 years: Autism was almost nonexistent, it was one out of 100,000. And now it’s close to one out of 100. I mean, what’s happening?” he asked.

When Welker insisted that studies have shown that there is no link between vaccines and autism, Trump allowed that “Maybe it’s not vaccines, maybe it’s chlorine in the water … I want them to look at everything.”

“Certain vaccines are incredible,” Trump said. “But maybe some aren’t, and if they aren’t, we have to find out.”

 

RFK Jr. is known for vehemently opposing vaccines, a stance he adopted after the mothers of vaccine-injured children implored him to look into the research linking thimerosal to neurological injuries, including autism. He went on to found Children’s Health Defense, an organization with the stated mission of “ending childhood health epidemics by eliminating toxic exposure,” largely through vaccines.

Kennedy said in October that Trump had asked him to reorganize and “clean up” federal health agencies like the CDC and FDA. This would involve ending conflicts of interest that favor the interests of pharmaceutical companies over evidence-based medicine, according to Kennedy.

He further shared that Trump had tasked him with ending “the chronic disease epidemic in this country,” especially chronic disease among children.

The future head of HHS recently described the unholy alliance between government health agencies and pharmaceutical companies. He explained how lucrative government-mandated children’s vaccines have been for the pharmaceutical industry:

There’s no downstream liability, there’s no front-end safety testing – that saves them a quarter billion dollars – and there’s no marketing and advertising costs, because the federal government is ordering 78 million school kids to take that vaccine every year.

What better product could you have? And so there was a gold rush to add all these new vaccines to the schedule that we don’t need. Most of these vaccines are unnecessary. Many of them are for diseases that are not even casually contagious.

It was a gold rush, because if you get onto that schedule, it’s a billion dollars a year for your company.

And in many cases, NIH is earning the royalties.

According to Kennedy, more obscene than the huge profits being horded by Big Pharma are the vast number of negative side effects from all those untested vaccines.

“Neurological diseases” have “exploded,” he said.

“ADHD, sleep disorders, language delays, ASD, autism, Tourette’s syndrome, ticks, narcolepsy. These are all things that I never heard of,” Kennedy said. “Autism went from one in 10,000 in my generation according to CDC data to one in every 34 kids today.”

RFK Jr. as future head of HHS scares Nobel laureates and The New York Times

Meanwhile, 77 Nobel laureates signed a letter urging the Senate to oppose Kennedy’s confirmation as head of HHS.

Thee New York Times described Kennedy as “a staunch critic of mainstream medicine” who “has been hostile to the scientists and agencies he would oversee.”

To many Americans, those are the perfect qualifications for the next head of HHS.

The laureates wrote:

The proposal to place Mr. Kennedy in charge of the federal agencies responsible for protecting the health of American citizens and for conducting the medical research that benefits our country and the rest of humanity has been widely criticized on multiple grounds. In addition to his lack of credentials or relevant experience in medicine, science, public health, or administration, Mr. Kennedy has been an opponent of many health-protecting and life-saving vaccines, such as those that prevent measles and polio; a critic of the well-established positive effects of fluoridation of drinking water; a promoter of conspiracy theories about remarkably successful treatments for AIDS and other diseases; and a belligerent critic of respected agencies (especially the Food and Drug Administration, the Centers for Disease Control, and the National Institutes of Health).

The leader of DHHS should continue to nurture and improve — not threaten — these important and highly respected institutions and their employees.

In view of his record, placing Mr. Kennedy in charge of DHHS would put the public’s health in jeopardy and undermine America’s global leadership in the health sciences, in both the public and commercial sectors.

It’s no surprise that those sitting atop the Big Pharma/Big Government/Academia industrial complex are displaying concern if not sheer desperation over Kennedy’s future role as head of HHS.

In October, Kennedy issued a warning on X:

FDA’s war on public health is about to end … If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags.

Public support for Kennedy’s quest is evident in the post having received nearly 7 million views and garnering 149,000 “Likes.”

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

COVID-19

Mel Gibson tells Joe Rogan about alternative cancer treatments, dangers of Remdesivir

Published on

From LifeSiteNews

By Stephen Kokx

In the wide-ranging interview, Mel Gibson told Joe Rogan about his experience with Remdesivir, the pharmaceutical industry and alternative treatments for cancer.

Mel Gibson discussed a wide range of issues with podcaster Joe Rogan this week, almost all of them eliciting strong reactions on social media, especially his comments on cancer and the medical establishment.  

Gibson contracted COVID-19 in April 2020. During a week-long hospital stay, he was administered the dangerous drug Remdesivir, which, despite having been known to have a mortality rate of over 50 percent in trials, was approved by Dr. Anthony Fauci for use in hospitals during the pandemic. 

Gibson told Rogan that the experimental treatment nearly ended his life. 

“[Remdesivir] kills you. I found that afterward. And that’s why I wonder about Fauci,” Gibson said.  

 

Hospitals were incentivized to use Remdesivir, which has been shown to cause kidney failure, after the U.S. government approved a 20 percent reimbursement bonus for its use. Medical facilities also  obtained money from the government for classifying deaths as being due to COVID-19. Critics allege that those policies enticed medical professionals to use the risky treatment in order to kill patients as a way to unethically boost profits. 

Gibson told Rogan that he acquired COVID from his gardener, who he had known for twenty years, but that he did not survive his illness. 

“We both went to the same hospital, and he died, and I didn’t … I think we both got Remdesivir, which is not good,” he explained.  

“I don’t know why Fauci’s still walking around… or at least free,” he further remarked. 

Gibson and Rogan also talked about cancer and Big Pharma. Gibson revealed that he knows people who have been healed from the illness due to alternative treatments.  

“I have three friends. All three of them had stage 4 cancer. All three of whom don’t have cancer right now at all. And they had some serious stuff going on,” Gibson said. 

“And what did they take?” Rogan asked. 

“They took …what you’ve heard they’ve taken,” he replied. 

“Ivermectin, Fenbendazole,” Rogan said. “I’m hearing that a lot.” 

“They drank hydrochloride something or other … people drinking methylene blue,” Gibson said.  

“There’s a lot of stuff that does work, which is very strange,” Rogan remarked. “Because, again, it’s profit, when you hear about things that are demonized and they turn out to be effective, you always wonder: ‘what is going on here?’ How is [sic] our medical institutions, how have they failed us so that things that do cure you are not promoted because they’re not profitable? They can’t control it. They don’t have a patent on it. Whether it’s Vitamin D, K2, Magnesium, Zinc. I do all that stuff.” 

On Friday morning, an X-approved post titled “Mel Gibson’s Cancer Cure Claim Sparks Medical Debate” was published on the trending section. Some users piggybacked on Gibson’s remarks by stating that they too have used or know people who are using treatments similar to the ones Gibson’s friends did and that “cancer research” is a racket. 

 

 

 

Others were unconvinced and re-iterated the media narrative that ivermectin is a simply a “dewormer.”

 

Elsewhere in their conversation, Gibson defended the authenticity of the Shroud of Turin and the historical reality of the resurrection of Christ, a topic Rogan has seemingly taken a heightened interest in recently given that he discussed the matter in depth on his show with a Protestant guest less than two weeks ago.  

Continue Reading

Alberta

Former AHS head, Dr. Chris Eagle will lead Acute Care Alberta

Published on

Refocusing acute care leadership for the future

Alberta’s government is bringing in the expertise and experience needed to continue refocusing the health care system for the benefit of all Albertans.

Alberta’s government is committed to refocusing the health care system so that Albertans can access the health care services they need when and where they need them. The work to transform the system is making significant progress, particularly with the recent launch of Primary Care Alberta in November 2024, and the continued advancement in establishing Alberta’s new acute care provincial health agency.

Acute care, which includes hospitals, emergency services and surgery care, is a significant part of the health care system, providing critical care to Albertans when they need it most. Acute Care Alberta, the new acute care provincial health agency, will work to speed up access to high-quality care, reduce wait times and make sure the patient’s journey through the system is efficient and effective across the province.

As progress is made to establish Acute Care Alberta, Alberta’s government is appointing Dr. Chris Eagle as chair and interim president and CEO. This appointment will take effect Feb. 1 to coincide with the establishment of Acute Care Alberta as a legal entity. Dr. Eagle’s focus will be on preparing the organization for its first day of operations later this spring. His appointment to the position is pending finalization of his contract.

Dr. Eagle has significant experience supporting and leading health care organizations and projects across Alberta, including his time as president and CEO of Alberta Health Services (AHS) from 2010 to 2013. His extensive experience in the health field will allow him to guide the work to operationalize Acute Care Alberta.

To help support Dr. Eagle’s work and to lead AHS through its transition from a regional health authority to a hospital-based service provider, Andre Tremblay, deputy minister of Alberta Health, has been appointed interim president and CEO of AHS.

“Acute care is the most complex part of the health care system, and it’s critical that we have the right leadership in place to see this work through and make positive changes to the health care system for Albertans now and into the future. I want to extend my sincerest gratitude to Athana Mentzelopoulos for the work she has done during her time leading Alberta Health Services.”

Adriana LaGrange, Minister of Health

Tremblay brings a wealth of public service and health care delivery experience to the position. With more than 20 years of public sector leadership, he has served in several senior leadership positions. Prior to joining Health in June 2023, Tremblay has been deputy minister at Education, Agriculture and Forestry, and Transportation. This is also his second leadership role at Alberta Health, having previously served as an associate deputy minister. He was also previously appointed as the deputy clerk of executive council and deputy secretary to cabinet. In his role as interim president and CEO, Tremblay will not receive a salary. His salary as deputy minister will remain the same.

Tremblay will continue as deputy minister through this critical period of transition and change for Alberta’s health care system. He will also oversee the recruitment of a permanent president and CEO for Acute Care Alberta. He is best positioned to continue leading efforts to refocus the health care system while supporting the transition of Alberta Health Services to an acute care service provider.

While in the interim role, Tremblay will work with AHS leadership to oversee operations, support staff transitions to Primary Care Alberta and establish Acute Care Alberta as a legal entity ahead of its operationalization this spring. Throughout this work, Albertans will continue to access acute care services as they always have and there will be no impact to front-line health care workers.

The AHS board of directors will begin the search for a permanent president and CEO immediately, and more details will be provided once the hiring process is complete.

“I am excited to take on this role and support the efforts to refocus Alberta’s health care system and to create an improved acute care system that will make sure Albertans have access to the best health care services they need, no matter where they live in the province.”

Dr. Chris Eagle, chair, and interim president and CEO, Acute Care Alberta

“We are at a critical time in the work that is underway to refocus the health care system. I am confident we can continue to make great strides to achieve the goal of making health care better for everyone in Alberta. I want to thank Athana Mentzelopoulos for her hard work, commitment and leadership during her time in the role.”

Angela Fong, board chair, Alberta Health Services

“We have made great progress refocusing the health care system and I am eager to take on this new role and support the work being done to improve health care across the province. I look forward to leading AHS as it transitions to a service delivery provider and engaging with front-line workers and staff across the system in the coming months.”

Andre Tremblay, interim president and CEO, Alberta Health Services, and deputy minister, Alberta Health
Continue Reading

Trending

X